API Holdings (together with its associates) is engaged in enterprise actions within the healthcare sector in India, which inter alia embody wholesale sale and distribution of pharmaceutical merchandise, medical gadgets and over-the-counter (OTC) merchandise, provision of diagnostic providers and provision of tele-medical session providers.
CDPQ funding
The competitors watchdog has given its nod for the proposed subscription of Compulsorily Convertible Choice Shares (CCPS) B in API Holdings Ltd by CDPQ Personal Fairness Asia Pte Ltd.
CDPQ Personal Fairness Asia Pte Ltd (acquirer) is a direct, wholly-owned subsidiary of CDPQ situated in Singapore.
CDPQ is a Canadian institutional fund, which acts as a long-term institutional investor that manages funds primarily for public and para-public pension and insurance coverage in Canada.
The Acquirer, CDPQ and their associates, are collectively known as the ‘Acquirer Group’.
API Holdings Ltd (Goal), via its subsidiaries, is engaged in working companies regarding healthcare providers, together with an internet e-commerce market, via a cell software in addition to an internet site known as ‘PharmEasy’; (ii) B2B (i.e., wholesale) sale and buy of pharmaceutical and nutraceutical merchandise, and warehousing, storing and packaging of such merchandise.
API Holdings proposes to boost capital via issuance of CCPS B by means of a rights Difficulty.
The acquirer is an current investor within the Goal and is a pre-emption proper holder. The acquirer ought to subscribe to the rights challenge by means of a major subscription, accompanied with sure rights.
NASPERS VENTURES
CCI has permitted the proposed acquisition of further shares of API Holdings Ltd by Naspers Ventures B.V.
Naspers Ventures B.V. (Acquirer), is an oblique, wholly-owned subsidiary of Prosus N.V. (Prosus), which is, in flip, a direct subsidiary of Naspers Ltd. (Naspers).
The Acquirer is an funding holding firm and its principal exercise is to make investments by offering direct and oblique fairness and debt funding.
API Holdings Ltd (Goal) is the last word guardian entity of the API Holdings group. Both instantly or via its subsidiaries/ affiliate corporations, the Goal is engaged in enterprise actions within the healthcare sector in India.
Naspers proposes to amass further shares of API Holdings byparticipating within the proposed rights challenge.
TEMASEK ENTITIES
The CCI has permitted the subscription of compulsorily convertible desire shares of API Holdings Ltd by MacRitchie Investments Pte. Ltd. and EvolutionX Debt Capital Grasp Fund 1 Pte. Ltd.
MacRitchie is an funding holding firm and doesn’t interact in any enterprise operation aside from holding investments. It’s an oblique wholly-owned subsidiary of Temasek Holdings (Pvt) Ltd (Temasek), being the last word guardian firm.
Temasek is an funding firm based mostly in Singapore. EvolutionX is a development stage debt financing platform collectively arrange by DBS Group Holdings Ltd and Temasek, headquartered in Singapore.
EvolutionX gives much less dilutive financing to technology-enabled corporations throughout Asia, with a give attention to India, China and South-East Asia.
The Goal is the last word guardian entity of the API Holdings group.
Goldman Sachs Various Funding
CCI has permitted subscription of compulsorily convertible desire shares of API Holdings Ltd by Goldman Sachs India AIF Scheme-1 and Goldman Sachs India Various Funding Belief AIF Scheme-2
Each schemes launched by Goldman Sachs India Various Funding Belief, have been arrange as a determinate belief underneath the Indian Trusts Act, 1882. Goldman Sachs (India) Various Funding Administration Pvt Ltd is the funding supervisor of Acquirer 1 and Acquirer 2.
#CCI #approves #a number of #mixtures #involving #Goldman #Sachs #Naspers #Temasek #CDPQs #investments #API #Holdings